Delivering etoposide to the brain using catanionic solid lipid nanoparticles with surface 5-HT-moduline

International Journal of Pharmaceutics

Volumn 465, Issue 1-2, 2014, Pages 132-142

  Kuo, Yung Chih ^a   Hong, Tsu Yu ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

5 HT moduline; Blood brain barrier; Catanionic surfactant; Endothelium; Etoposide; Solid lipid nanoparticle

Indexed keywords

CATANIONIC SOLID LIPID NANOPARTICLE; ETOPOSIDE; LEUCYLSERYLALANYLLEUCINE; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; 5-HT-MODULINE; ANTINEOPLASTIC AGENT; CATION; DRUG CARRIER; LIPID; NANOPARTICLE; NEUROPEPTIDE; OLIGOPEPTIDE; SURFACTANT; PROPIDIUM IODIDE; SEROTONIN 1B RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CANCER CHEMOTHERAPY; CELL VIABILITY; CONFOCAL LASER SCANNING MICROSCOPE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SOLUBILITY; DRUG TARGETING; ELECTRIC RESISTANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; LASER DOPPLER FLOWMETRY; MICROEMULSION; MICROVASCULAR ENDOTHELIAL CELL; NANOENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; ZETA POTENTIAL; CAPILLARY PERMEABILITY; CELL LINE; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; ENDOTHELIUM CELL; IMPEDANCE; MEDICINAL CHEMISTRY; METABOLISM; NANOTECHNOLOGY; PHARMACEUTICS; PROCEDURES; TIGHT JUNCTION; TOXICITY; CAPILLARY ENDOTHELIAL CELL; COLLOID; DRUG TRANSPORT; INTERNALIZATION; LIPID COMPOSITION; MICELLIZATION; SHEAR STRESS; SURFACE CHARGE; SURFACE PROPERTY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; CATIONS; CELL LINE; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; ETOPOSIDE; HUMANS; LIPIDS; NANOPARTICLES; NANOTECHNOLOGY; NEUROPEPTIDES; OLIGOPEPTIDES; PARTICLE SIZE; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL; TIGHT JUNCTIONS;

EID: 84896749563     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.02.008     Document Type: Article

References (63)

1. N.J. Abbott Dynamics of CNS barriers: evolution, differentiation and modulation Cellular and Molecuar Neurobiology 25 2005 5 23
2. N.J. Abbott Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology Neurochemistry International 45 2004 545 552
3. J. Aguiar, P. Carpena, J.A. Molina-Bolivar, and C.C. Ruiz On the determination of the critical micelle concentration by the pyrene 1:3 ratio method Journal of Colloid and Interface Science 258 2003 116 122
4. C. Aiello, P. Andreozzi, C.L. Mesa, and G. Risuleo Biological activity of SDS-CTAB cat-anionic vesicles in cultured cells and assessment of their cytotoxicity ending in apoptosis Colloids and Surfaces B 78 2010 149 154
5. M.A. Bahri, M. Hoebeke, A. Grammenos, L. Delanaye, N. Vandewalle, and A. Seret Investigation of SDS, DTAB and CTAB micelle microviscosities by electron spin resonance Colloids and Surfaces A 290 2006 206 212
6. M. Bredel Anticancer drug resistance in primary human brain tumors Brain Research Reviews 35 2001 161 204
7. H. Bunjes, and T. Unruh Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering Advanced Drug Delivery Reviews 59 2007 379 402
8. 4+ memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layer Journal of Neuroimmunology 153 2004 150 157
9. M. Callewaert, S. Dukic, L. Van Gulick, M. Vittier, V. Gafa, M.C. Andry, M. Molinari, and V.G. Roullin Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency Journal of Biomedical Materials Research A 101 2013 1319 1327
10. H.B. de Aguiar, M.L. Strader, A.G. de Beer, and S. Roke Surface structure of sodium dodecyl sulfate surfactant and oil at the oil-in-water droplet liquid/liquid interface: a manifestation of a nonequilibrium surface state The Journal of Physical Chemistry B 115 2011 2970 2978
11. T. Eldem, P. Speiser, and A. Hincal Optimization of spray-dried and congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy Pharmaceutical Research 8 1991 47 54
12. C.B. Fernandes, S. Mandawgade, and V.B. Patravale Solid lipid nanoparticles of etoposide using solvent emulsification diffusion technique for parenteral administration International Journal of Pharma Bioscience and Technology 1 2013 27 33
13. N.F. Flecher, D.J. Brayden, B. Brankin, S. Worrall, and J.J. Callanan Growth and characterisation of a cell culture model of the feline blood-brain barrier Veterinary Immunology and Immunopathology 109 2006 233 244
14. C. Freitas, and R.H. Muller Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions International Journal of Pharmaceutics 168 1998 221 229
15. A. Fundaro, R. Cavalli, A. Bagoni, D. Vighetto, G.P. Zara, and M.R. Gasco Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin pharmacokinetics and tissue distribution after i.v. administration to rats Pharmaceutical Research 42 2000 337 343
16. R. Gabathuler Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases Neurobiology of Disease 37 2010 48 57
17. P.J. Gaillard, and A.G. de Boer Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug European Journal of Pharmaceutical Sciences 12 2000 95 102
18. P.L. Golden, T.J. Maccagnan, and W.M. Pardridge Human blood-brain barrier leptin receptor: binding and endocytosis in isolated human brain microvessels Journal of Clinical Investigation 99 1997 14 18
19. 1B receptor agonist reduces serotonin synthesis following acute, and not chronic, drug administration: results of an autoradiographic study Neurochemistry International 46 2005 261 272
20. D.Z. Hou, C.S. Xie, K.J. Huang, and C.H. Zhu The production and characteristics of solid lipid nanoparticles (SLNs) Biomaterials 24 2003 1781 1785
21. A.R. Jones, and E.V. Shusta Blood-brain barrier transport of therapeutics via receptor-mediation Pharmaceutical Research 24 2007 1759 1771
22. C.F. Jones, and D.W. Grainger In vitro assessments of nanomaterial toxicity Advanced Drug Delivery Reviews 61 2009 438 456
23. A.J. Kaumann, and F.O. Levy 5-Hydroxytryptamine receptors in the human cardiovascular system Pharmacology Therapeutics 111 2006 674 706
24. K.M. Kroeger, A.K. Muhammad, G.J. Baker, H. Assi, M.K. Wibowo, W. Xiong, K. Yagiz, M. Candolfi, P.R. Lowenstein, and M.G. Castro Gene therapy and virotherapy: novel therapeutic approaches for brain tumors Discovery Medicine 10 2010 293 304
25. J.S. Kuo, C.H. Chang, Y.L. Lin, and C.J. Wu Flow cytometric characterization of interactions between U-937 human macrophages and positively charged catanionic vesicles Colloids Surfaces B 64 2008 307 313
26. Y.C. Kuo, and L.J. Wang Transferrin-grafted catanionic solid lipid nanoparticles for targeting delivery of saquinavir to the brain Journal of the Taiwan Institute Chemical Engineers 2014 (in press) http://dx.doi.org/10.1016/j. jtice.2013.09.024
27. Y.C. Kuo, and H.F. Ko Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles Biomaterials 34 2013 4818 4830
28. Y.C. Kuo, and C.Y. Shih-Huang Solid lipid nanoparticles carrying chemotherapeutic drug across the blood-brain barrier through insulin receptor-mediated pathway Journal of Drug Targeting 21 2013 730 738
29. Y.C. Kuo, and C.L. Lee Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier Colloids Surfaces B 90 2012 75 82
30. Y.C. Kuo, and C.H. Lu Modulation of efflux proteins by electromagnetic field for delivering azidothymidine and saquinavir into the brain Colloids Surfaces B 91 2012 291 295
31. Y.C. Kuo, and C.T. Liang Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells Colloids Surfaces B 85 2011 131 137
32. Y.C. Kuo, and C.T. Liang Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor Biomaterials 32 2011 3340 3350
33. Y.C. Kuo, P.I. Lin, and C.C. Wang Targeting nevirapine delivery across human brain microvesscular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles Nanomedicine 6 2011 1011 1026
34. Y.C. Kuo, and C.H. Lu Effect of human astrocytes on the characteristics of human brain-microvascular endothelial cells in the blood-brain barrier Colloids Surfaces B 86 2011 225 231
35. Y.C. Kuo, and H.W. Yu Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drug Colloids Surfaces B 88 2011 158 164
36. Y.C. Kuo, and H.W. Yu Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid) International Journal of Pharmaceutics 416 2011 365 375
37. Y.C. Kuo, and H.H. Chen Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells Journal of Drug Targeting 18 2010 447 456
38. Y.C. Kuo, and C.W. Lin Impact of arginine-modified solid lipid nanoparticles on the membrane charge of human brain-microvascular endothelial cells Colloids Surfaces B 72 2009 201 207
39. Y.C. Kuo, and C.Y. Kuo Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers International Journal of Pharmaceutics 351 2008 271 281
40. Y.C. Kuo, and F.L. Su Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate- sulfopropylmethacrylate, and solid lipid nanoparticles International Journal of Pharmacetics 340 2007 143 152
41. D. Lin, and L.H. Parsons Anxiogenic-like effect of serotonin (1B) receptor stimulation in the rat elevated plus-maze Pharmacology Biochemistry and Behavior 71 2002 581 587
42. J.L. Lopez-Fontan, E. Blanco, J.M. Ruso, M. Prieto, P.C. Schulz, and F. Sarmiento The aqueous catanionic system sodium perfluorooctanoate- dodecyltrimethylammonium bromide at low concentration Journal of Colloid Interface Science 312 2007 425 431
43. K. Malssen, A. Langevelde, R. Peschar, and H. Schenk Phase behavior and extended phase scheme of static cocoa butter investigated with real-time X-ray powder diffraction Journal of American Oil Chemist's Society 76 1999 669 676
44. O. Massot, J.C. Rousselle, M.P. Fillion, B. Grimaldi, I. Cloez-Tayarani, A. Fugelli, N. Prudhomme, L. Seguin, B. Rousseau, M. Plantefol, R. Hen, and G. Fillion 5-hydroxytryptamine-moduline, a new endogenous cerebral tetrapeptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors Molecular Pharmacology 50 1996 752 762
45. W. Mehnert, and K. Mader Solid lipid nanoparticles production, characterization and applications Advanced Drug Delivery Reviews 47 2001 165 196
46. R.H. Muller, K. Mader, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art European Journal of Pharmaceutics and Biopharmaceutics 50 2000 161 177
47. R.H. Muller, S. Maassen, C. Schwarz, and W. Mehnert Solid lipid nanopaticles (SLN) as potential carrier for human use: interaction with human granulocytes Journal of Controlled Release 47 1997 261 269
48. S. Nag, and D.J. Begley Blood-brain barrier, exchange of metabolites and gases H. Kalimo, Pathology and Genetics Cerebrovascular Diseases 2005 ISN Neuropath Press Basel 22 29
49. W. Pan, and A.J. Kastin Adipokines and the blood-brain barrier Peptides 28 2007 1317 1330
50. W.M. Pardridge The blood-brain barrier: bottleneck in brain drug development NeuroRx 2 2005 3 14
51. 1B antimigraine drug receptor in rat and human brain microvessels Neuroscience 86 1998 1031 1035
52. 1B receptors The Journal of Biological Chemistry 271 1996 726 735
53. M.A. Schubert, M. Harms, and C.C. Muller-Goymann Structural investigations on lipid nanoparticles containing high amounts of lecithin European Journal of Pharmaceutical Sciences 27 2006 226 236
54. S.J. See, and M.R. Gilbert Anaplastic astrocytoma: diagnosis, prognosis, and management Seminars in Oncology 31 2004 618 634
55. 1B receptor function by p11 in depression-like states Science 11 2006 77 80
56. 1B receptor agonist CP 94253: a possible mechanism of action European Journal of Pharmacology 516 2005 46 50
57. V. Teeranachaideekul, R.H. Muller, and V.B. Junyaprasertv Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC) - effects of formulation parameters on physicochemical stability International Journal of Pharmaceutics 340 2007 198 206
58. S. Wagner, A. Zensi, S.L. Wien, S.E. Tschickardt, W. Maier, T. Vogel, F. Worek, C.U. Pietrzik, J. Kreuter, and H.V. Briesen Uptake mechanism of apoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model PLoS One 7 2012 e32568
59. J.X. Wang, X. Sun, and Z.R. Zhang Enhanced brain targeting by synthesis of 3′,5′-dioctanoyl-5-fluoro-2′-deoxyuridine and incorporation into solid lipid nanoparticles European Journal of Pharmaceutics and Biopharmaceutics 54 2002 285 290
60. J. Williams, R. Lansdown, R. Sweitzer, M. Romanowski, R. LaBell, R. Ramaswami, and E. Unger Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors Journal of Controlled Release 91 2003 167 172
61. H. Wolburg, and A. Lippoldt Tight junctions of the blood-brain barrier: development, composition and regulation Vascular Pharmacology 38 2002 323 337
62. Z. Xu, L. Chen, W. Gu, Y. Gao, L. Lin, Z. Zhang, Y. Xi, and Y. Li The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma Biomaterials 30 2009 226 232
63. S.C. Yang, L.F. Lu, Y. Cai, J.B. Zhu, B.W. Liang, and C.Z. Yang Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain Journal of Controlled Release 59 1999 299 307